<td id="mz9u0"><option id="mz9u0"></option></td>
  • 中文版    |    English
      Tel +86-571-88737065   QQ Online

    Company profile

    Welcome to Synbest biotech

    Established by senior chemists and marketing experts in Hangzhou, SYNBEST (SYNBEST) is specialized manufacturer of fine chemicals which are widely applied in pharmaceuticals, argochemicals, electronic chemicals, nutrition, cosmetics and surfactants.

    The headquarters of SYNBEST is located in the Zhejiang University Alumni Headquarters Economic Park, Future Science and Technology City, Hangzhou, Zhejiang Province. Established with a research and development center covering an area of 2200 square meters, equipped with 55 standard fume hoods and advanced analytical instruments. And a pilot plant has been established in Shaoxing, which can complete the production and process validation of multi-step process 10-100kg. We establishes two manufacturing facilities in Henan Province and Anhui Province.

    SYNBEST has a professional team that is composed of chemists with more than 20 years' experience in organic chemical field. Our chemists expert in the design of innovative chemistry processes, project management according to any strict requirements we are requested to follow. So we can meet clients' outsourcing needs by offering cost-effective and time-efficient and products.

    Since its establishment, the company has received multiple honorary titles: "Zhejiang Province Science and Technology Small and Medium sized Enterprise", "Hangzhou High tech Enterprise", "National High tech Enterprise", and "Specialized, refined, and innovative" Enterprise.

    Our mission: provide high quality product on time with competitive price.

    Our Product

    Established by senior chemists and marketing experts in Hangzhou, SYNBEST (SYNBEST) is specialized manufacturer of fine chemicals which are widely applied in pharmaceuticals, argochemicals, electronic chemicals, nutrition, cosmetics and surfactants.

    Company News

    - 2019-07-05

    FDA Approves Xpovio

      FDA Approves Xpovio (selinexor) for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma

    - 2019-07-04

    New synthetic technology for medicines and fine chemicals

      A University of Tokyo research group has succeeded in synthesizing (R)- and (S)-rolipram, the active component of

    Online services
    Tel
    +86-571-88737065
    国产三香港三韩国三级,和熟妇的同学麻麻,日韩精品久久无码中文字幕,97超超超碰碰碰碰碰碰